Omeros Number of Employees 2010-2024 | OMER
Omeros Annual Employee Count | |
---|---|
2023 | 198 |
2022 | 196 |
2021 | 213 |
2020 | 277 |
2019 | 258 |
2018 | 236 |
2017 | 173 |
2016 | 154 |
2015 | 162 |
2014 | 103 |
2013 | 75 |
2012 | 71 |
2011 | 70 |
2010 | 70 |
2009 | 67 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.227B | $0.000B |
Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve postoperative joint function and reduce postoperative pain. Omeros is also building a diverse pipeline of preclinical programs targeting inflammation and central nervous system disorders. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $196.139B | 25.33 |
Stryker (SYK) | United States | $137.702B | 32.18 |
Boston Scientific (BSX) | United States | $122.346B | 37.26 |
Medtronic (MDT) | Ireland | $114.719B | 17.07 |
EssilorLuxottica (ESLOY) | France | $106.985B | 0.00 |
Haleon (HLN) | United Kingdom | $48.286B | 35.30 |
Lonza Group Ag (LZAGY) | Switzerland | $46.218B | 0.00 |
ResMed (RMD) | United States | $35.640B | 31.38 |
Koninklijke Philips (PHG) | Netherlands | $29.674B | 22.55 |
Terumo (TRUMY) | Japan | $28.204B | 39.83 |
Zimmer Biomet Holdings (ZBH) | United States | $21.935B | 13.81 |
Baxter (BAX) | United States | $19.749B | 13.39 |
Insulet (PODD) | United States | $16.507B | 69.45 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.465B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $9.256B | 30.67 |
Demant (WILYY) | Denmark | $8.667B | 0.00 |
BellRing Brands (BRBR) | United States | $7.864B | 33.25 |
Lantheus Holdings (LNTH) | United States | $7.251B | 17.41 |
ICU Medical (ICUI) | United States | $4.262B | 40.67 |
Haemonetics (HAE) | United States | $3.918B | 19.38 |
Neogen (NEOG) | United States | $3.612B | 37.89 |
TG Therapeutics (TGTX) | United States | $3.612B | 38.25 |
GN Store Nord (GNNDY) | Denmark | $3.576B | 21.54 |
Prestige Consumer Healthcare (PBH) | United States | $3.536B | 17.62 |
Perrigo (PRGO) | Ireland | $3.496B | 11.05 |
Envista Holdings (NVST) | United States | $3.310B | 17.66 |
QuidelOrtho (QDEL) | United States | $2.970B | 18.72 |
Agios Pharmaceuticals (AGIO) | United States | $2.734B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $2.220B | 37.25 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.109B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $2.029B | 54.07 |
Warby Parker (WRBY) | United States | $1.620B | 0.00 |
InMode (INMD) | Israel | $1.444B | 9.19 |
AdaptHealth (AHCO) | United States | $1.385B | 10.00 |
AtriCure (ATRC) | United States | $1.384B | 0.00 |
Owens & Minor (OMI) | United States | $1.213B | 9.36 |
Verano Holdings (VRNOF) | United States | $1.199B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.115B | 0.00 |
Evolus (EOLS) | United States | $1.032B | 0.00 |
PetIQ (PETQ) | United States | $0.919B | 23.29 |
Phibro Animal Health (PAHC) | United States | $0.895B | 18.57 |
National Vision Holdings (EYE) | United States | $0.852B | 27.10 |
Cresco Labs (CRLBF) | United States | $0.820B | 0.00 |
Surmodics (SRDX) | United States | $0.549B | 116.58 |
Quanterix (QTRX) | United States | $0.498B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.483B | 14.57 |
ZimVie (ZIMV) | United States | $0.430B | 39.97 |
Valneva SE (VALN) | France | $0.425B | 0.00 |
Jin Medical (ZJYL) | China | $0.422B | 0.00 |
Canopy Growth (CGC) | Canada | $0.397B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.386B | 0.00 |
Cerus (CERS) | United States | $0.330B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.325B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.318B | 8.19 |
Aurora Cannabis (ACB) | Canada | $0.314B | 0.00 |
Biote (BTMD) | United States | $0.295B | 13.62 |
Viemed Healthcare (VMD) | United States | $0.281B | 30.17 |
Zynex (ZYXI) | United States | $0.262B | 45.89 |
Sanara MedTech (SMTI) | United States | $0.254B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.233B | 15.45 |
Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
MacroGenics (MGNX) | United States | $0.191B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.191B | 0.00 |
High Tide (HITI) | Canada | $0.157B | 65.00 |
FitLife Brands (FTLF) | United States | $0.152B | 20.55 |
Brainsway (BWAY) | Israel | $0.137B | 164.20 |
TriSalus Life Sciences (TLSI) | United States | $0.122B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.122B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.117B | 0.00 |
Veru (VERU) | United States | $0.114B | 0.00 |
Fonar (FONR) | United States | $0.112B | 11.39 |
Jushi Holdings (JUSHF) | United States | $0.105B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.098B | 24.00 |
Zevia PBC (ZVIA) | United States | $0.085B | 0.00 |
InterCure (INCR) | Israel | $0.083B | 14.08 |
Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
Modular Medical (MODD) | United States | $0.077B | 0.00 |
Safety Shot (SHOT) | United States | $0.072B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.068B | 0.00 |
MariMed (MRMD) | United States | $0.065B | 0.00 |
Exagen (XGN) | United States | $0.055B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.053B | 3.44 |
Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
Apyx Medical (APYX) | United States | $0.041B | 0.00 |
ImmuCell (ICCC) | United States | $0.028B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
Nephros (NEPH) | United States | $0.019B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.009B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.007B | 0.00 |
Agape ATP (ATPC) | $0.007B | 0.00 | |
Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.001B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 21.89 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |